Jacco Heldens

900 citations

22 papers · 686 indexed · h-index 14

Co-authors: Han van den Bosch Harrie L. Glansbeek Niels Hagenaars Enrico Mastrobattista Wim Jiskoot J. T. M. Voeten Larisa Rudenko Irina Kiseleva
Topics: Influenza Virus Research Studies (15 papers)Respiratory viral infections research (11 papers)Viral gastroenteritis research and epidemiology (5 papers)
Cited by: Pharmaceutical Science Epidemiology Infectious Diseases
Journals: Journal of Virology Journal of Controlled Release Journal of Clinical Microbiology
Partner nations: Netherlands United States Russia

In The Last Decade

Jacco Heldens

22 papers receiving 670 citations

Peers

Countries citing papers authored by Jacco Heldens

Since Specialization

Citations

This map shows the geographic impact of Jacco Heldens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacco Heldens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacco Heldens more than expected).

Fields of papers citing papers by Jacco Heldens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacco Heldens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacco Heldens. The network helps show where Jacco Heldens may publish in the future.

Co-authorship network of co-authors of Jacco Heldens

This figure shows the co-authorship network connecting the top 25 collaborators of Jacco Heldens. A scholar is included among the top collaborators of Jacco Heldens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacco Heldens. Jacco Heldens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibodies enhance CXCL10 production during RSV infection of infant and adult immune cells 2015 ·Cytokine ·(unknown),(unknown),(unknown),Jacco Heldens,Ronald de Groot,Marien I. de Jonge,Gerben Ferwerda	10
2	Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: A Phase I dose escalating study in healthy volunteers 2014 ·Vaccine ·Jacco Heldens,Ellen G. J. Hulskotte,(unknown),(unknown),Paul E. Verweij,Wilbert van Duijnhoven,(unknown),Pierre Van Damme,Han van den Bosch	7
3	Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity 2013 ·Reviews in Medical Virology ·(unknown),(unknown),Jacco Heldens,Marien I. de Jonge,Ofer Levy,Gerben Ferwerda	9
4	An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting 2012 ·Virology Journal ·(unknown),Xu Fang,(unknown),Jacco Heldens,Willem Huisman,Myra N. Widjojoatmodjo	38
5	Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells 2011 ·Virology Journal ·Stefan Metz,Corinne Geertsema,B Martina,Paulina Andrade,Jacco Heldens,Monique M. van Oers,Rob Goldbach,Just M. Vlak,Gorben P. Pijlman	87
6	Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2) 2011 ·Virology ·Irina Isakova–Sivak,Li-Mei Chen,Yumiko Matsuoka,J. T. M. Voeten,Irina Kiseleva,Jacco Heldens,Han van den Bosch,Alexander Klimov,Larisa Rudenko,Nancy J. Cox,Rubén O. Donis	80
7	Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay 2011 ·Vaccine ·(unknown),(unknown),(unknown),(unknown),(unknown),Harrie L. Glansbeek,(unknown),Jacco Heldens,Edwin R. van den Heuvel	5
8	A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N,N,N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccine 2011 ·European Journal of Pharmaceutical Sciences ·Rolf J. Verheul,Niels Hagenaars,(unknown),Ethlinn V.B. van Gaal,(unknown),Sven C. M. Bruijns,Enrico Mastrobattista,Bram Slütter,Ivo Que,Jacco Heldens,Han van den Bosch,Harrie L. Glansbeek,Wim E. Hennink,Wim Jiskoot	11
9	Genome composition analysis of reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine 2011 ·Molecular Genetics Microbiology and Virology ·Irina Kiseleva,J. T. M. Voeten,(unknown),Natalie Larionova,(unknown),(unknown),(unknown),H. van den Bosch,Jacco Heldens,Larisa Rudenko	12
10	Comparative Immunogenicity and Cross-Clade Protective Efficacy of Mammalian Cell-Grown Inactivated and Live Attenuated H5N1 Reassortant Vaccines in Ferrets 2011 ·The Journal of Infectious Diseases ·Kortney M. Gustin,Taronna R. Maines,Jessica A. Belser,Neal Van Hoeven,Xiaoyan Lu,L. Y. Dong,Irina Isakova–Sivak,Liming Chen,J. T. M. Voeten,Jacco Heldens,Han van den Bosch,(unknown),Terrence M. Tumpey,(unknown),Larisa Rudenko,Rubén O. Donis,(unknown)	38
11	Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model 2010 ·Archives of Virology ·J. T. M. Voeten,Irina Kiseleva,Harrie L. Glansbeek,(unknown),(unknown),Larisa Rudenko,Han van den Bosch,Jacco Heldens	6
12	Feasibility of single-shot H5N1 influenza vaccine in ferrets, macaques and rabbits 2010 ·Vaccine ·Jacco Heldens,Harrie L. Glansbeek,Luuk Hilgers,(unknown),Koert J. Stittelaar,Albert D. M. E. Osterhaus,(unknown)	13
13	Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine 2010 ·Journal of Controlled Release ·Niels Hagenaars,(unknown),(unknown),Ivo Que,(unknown),Bram Slütter,Harrie L. Glansbeek,Jacco Heldens,Han van den Bosch,Clemens W.G.M. Löwik	54
14	A Single Immunization with CoVaccine HT-Adjuvanted H5N1 Influenza Virus Vaccine Induces Protective Cellular and Humoral Immune Responses in Ferrets 2010 ·Journal of Virology ·Rogier Bodewes,Joost H. C. M. Kreijtz,Geert van Amerongen,Martina M. Geelhoed-Mieras,R. Joyce Verburgh,Jacco Heldens,J Bedwell,Judith M. A. van den Brand,Thijs Kuiken,Carel A. van Baalen,Ron A. M. Fouchier,Albert D. M. E. Osterhaus,Guus F. Rimmelzwaan	32
15	The novel adjuvant CoVaccineHT™ increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro 2009 ·Vaccine ·Rogier Bodewes,Martina M. Geelhoed-Mieras,Jacco Heldens,(unknown),Bart N. Lambrecht,Ron A. M. Fouchier,Albert D. M. E. Osterhaus,Guus F. Rimmelzwaan	18
16	PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus 2009 ·Journal of General Virology ·Irina Kiseleva,J. T. M. Voeten,(unknown),Natalie Larionova,(unknown),(unknown),Jacco Heldens,H. van den Bosch,Larisa Rudenko	32
17	Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine 2009 ·Journal of Controlled Release ·Niels Hagenaars,Rolf J. Verheul,(unknown),(unknown),Enrico Mastrobattista,Harrie L. Glansbeek,Jacco Heldens,Han van den Bosch,Wim E. Hennink,Wim Jiskoot	49
18	Physicochemical and Immunological Characterization of N,N,N-Trimethyl Chitosan-Coated Whole Inactivated Influenza Virus Vaccine for Intranasal Administration 2009 ·Pharmaceutical Research ·Niels Hagenaars,Enrico Mastrobattista,Rolf J. Verheul,(unknown),Harrie L. Glansbeek,Jacco Heldens,Han van den Bosch,Wim Jiskoot	47
19	Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model 2008 ·Vaccine ·Niels Hagenaars,Enrico Mastrobattista,Harrie L. Glansbeek,Jacco Heldens,Han van den Bosch,Virgil E.J.C. Schijns,Didier Betbeder,Herman Vromans,Wim Jiskoot	65
20	Cloning and characterization of the bgxA gene from Erwinia chrysanthemi D1 which encodes a β-glucosidase/xylosidase enzyme 1995 ·Molecular and General Genetics MGG ·(unknown),Jacco Heldens,Carol Boyd,Bernard Henrissat,Noel T. Keen	32

About Jacco Heldens

Jacco Heldens is a scholar working on Pharmaceutical Science, Epidemiology and Infectious Diseases, having authored 22 papers that have together received 686 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (15 papers), Respiratory viral infections research (11 papers) and Viral gastroenteritis research and epidemiology (5 papers). The work is most often cited by research in Pharmaceutical Science (109 citations), Epidemiology (387 citations) and Infectious Diseases (193 citations). Jacco Heldens has collaborated with scholars based in Netherlands, United States and Russia. Frequent co-authors include Han van den Bosch, Harrie L. Glansbeek, Niels Hagenaars, Enrico Mastrobattista, Wim Jiskoot, J. T. M. Voeten, Larisa Rudenko, Irina Kiseleva, Rolf J. Verheul and Monique M. van Oers. Their work appears in journals such as Journal of Virology, Journal of Controlled Release and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact